Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larissa A Pikor

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Trends in Cancer|July 26, 2017
Oncolytic Viruses: Exploiting Cancer's Deal with the DevilLarissa A Pikor, John C Bell, Jean-Simon Diallo
Frontiers in Immunology|July 31, 2025
Navigating the manufacturing, testing and regulatory complexities of regulatory T cells for adoptive cell therapyLarissa A Pikor, Sindhu Arivazhagan, Michael Mendicino, et al.
Lung Cancer (Amsterdam, Netherlands)|September 10, 2013
Genetic alterations defining NSCLC subtypes and their therapeutic implicationsLarissa A Pikor, Varune R Ramnarine, Stephen Lam, et al.
Journal of Visualized Experiments : Jove|April 15, 2011
DNA extraction from paraffin embedded material for genetic and epigenetic analysesLarissa A Pikor, Katey S S Enfield, Heryet Cameron, et al.
Genetics Research International|August 2, 2012
Mechanistic Roles of Noncoding RNAs in Lung Cancer Biology and Their Clinical ImplicationsKatey S S Enfield, Larissa A Pikor, Victor D Martinez, et al.
Journal of Cellular Physiology|December 19, 2009
Methylation analysis by DNA immunoprecipitationKelsie L Thu, Larissa A Pikor, Jennifer Y Kennett, et al.
Head & Neck|March 6, 2014
Disruption of KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex components by multiple genetic mechanisms: Association with poor prognosis in head and neck cancerVictor D Martinez, Emily A Vucic, Kelsie L Thu, et al.
Biomed Research International|August 13, 2014
Unique pattern of component gene disruption in the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in serous ovarian cancerVictor D Martinez, Emily A Vucic, Kelsie L Thu, et al.
Molecular Cancer|October 22, 2013
Frequent concerted genetic mechanisms disrupt multiple components of the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in thyroid cancerVictor D Martinez, Emily A Vucic, Larissa A Pikor, et al.
Oncoscience|January 17, 2015
SOX15 and other SOX family members are important mediators of tumorigenesis in multiple cancer typesKelsie L Thu, Daiana D Becker-Santos, Nikolina Radulovich, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Trends in Cancer|July 26, 2017
Oncolytic Viruses: Exploiting Cancer's Deal with the DevilLarissa A Pikor, John C Bell, Jean-Simon Diallo
Frontiers in Immunology|July 31, 2025
Navigating the manufacturing, testing and regulatory complexities of regulatory T cells for adoptive cell therapyLarissa A Pikor, Sindhu Arivazhagan, Michael Mendicino, et al.
Lung Cancer (Amsterdam, Netherlands)|September 10, 2013
Genetic alterations defining NSCLC subtypes and their therapeutic implicationsLarissa A Pikor, Varune R Ramnarine, Stephen Lam, et al.
Journal of Visualized Experiments : Jove|April 15, 2011
DNA extraction from paraffin embedded material for genetic and epigenetic analysesLarissa A Pikor, Katey S S Enfield, Heryet Cameron, et al.
Genetics Research International|August 2, 2012
Mechanistic Roles of Noncoding RNAs in Lung Cancer Biology and Their Clinical ImplicationsKatey S S Enfield, Larissa A Pikor, Victor D Martinez, et al.
Journal of Cellular Physiology|December 19, 2009
Methylation analysis by DNA immunoprecipitationKelsie L Thu, Larissa A Pikor, Jennifer Y Kennett, et al.
Head & Neck|March 6, 2014
Disruption of KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex components by multiple genetic mechanisms: Association with poor prognosis in head and neck cancerVictor D Martinez, Emily A Vucic, Kelsie L Thu, et al.
Biomed Research International|August 13, 2014
Unique pattern of component gene disruption in the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in serous ovarian cancerVictor D Martinez, Emily A Vucic, Kelsie L Thu, et al.
Molecular Cancer|October 22, 2013
Frequent concerted genetic mechanisms disrupt multiple components of the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in thyroid cancerVictor D Martinez, Emily A Vucic, Larissa A Pikor, et al.
Oncoscience|January 17, 2015
SOX15 and other SOX family members are important mediators of tumorigenesis in multiple cancer typesKelsie L Thu, Daiana D Becker-Santos, Nikolina Radulovich, et al.
Pageof 3